These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31256946)

  • 1. Revisiting the activated protein C-protein S-thrombomodulin ternary pathway: Impact of new understanding on its laboratory investigation.
    Amiral J; Seghatchian J
    Transfus Apher Sci; 2019 Aug; 58(4):538-544. PubMed ID: 31256946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein C system and thrombosis diseases].
    Taran LD
    Ukr Biokhim Zh (1999); 2003; 75(1):18-24. PubMed ID: 14574731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of blood coagulation.
    Esmon CT
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):349-60. PubMed ID: 10708869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.
    Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM
    J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.
    Dhainaut JF; Yan SB; Cariou A; Mira JP
    Crit Care Med; 2002 May; 30(5 Suppl):S318-24. PubMed ID: 12004254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of protein C in congenital and acquired thrombotic disorders.
    Housholder GT
    J Oral Maxillofac Surg; 1988 Sep; 46(9):781-7. PubMed ID: 2842484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
    Dahlbäck B
    Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients.
    Boldt J; Schindler E; Welters I; Wittstock M; Stertmann WA; Hempelmann G
    Anaesthesia; 1995 Nov; 50(11):954-60. PubMed ID: 8678251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness.
    Esmon CT
    Crit Care; 2001; 5(2):S7-12. PubMed ID: 11379986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the inflammatory response on coagulation.
    Esmon CT
    Thromb Res; 2004; 114(5-6):321-7. PubMed ID: 15507261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protein C, protein S and thrombomodulin: one of the natural antithrombotic mechanisms].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Rev Invest Clin; 1990; 42(1):54-62. PubMed ID: 2173090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
    Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
    Lebreton A; Sinegre T; Pereira B; Lamblin G; Duron C; Abergel A
    J Gastroenterol Hepatol; 2017 Apr; 32(4):916-924. PubMed ID: 27421039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombomodulin in intensive care patients.
    Boldt J; Wollbrück T; Sonneborn S; Welters A; Hempelmann G
    Intensive Care Med; 1995 Aug; 21(8):645-50. PubMed ID: 8522668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface.
    Esmon CT
    FASEB J; 1995 Jul; 9(10):946-55. PubMed ID: 7615164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
    Somajo S; Koshiar RL; Norström E; Dahlbäck B
    Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipids.
    Freyssinet JM; Beretz A; Klein-Soyer C; Gauchy J; Schuhler S; Cazenave JP
    Biochem J; 1988 Dec; 256(2):501-7. PubMed ID: 2851994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.